Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
上海药明生物技术有限公司 Wuxi Biologics
{{company.company_channel.channel_name}}
Media Room
Latest
Photos
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Follow :
X
Company Profile
Media Room
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.title}}
loading
The End
Network Errors Please Retry
{{selectname}}
{{showName}}
{{selectall}}
{{option}}
WuXi Biologics Receives Bioprocessing Excellence Award from IMAPAC
2022-04-15 09:03
WuXi Biologics Achieved Record Growth and Profitability in 2021
2022-03-23 00:38
WuXi Biologics Recognized as 2022 Top-Rated ESG Company by Sustainalytics
2022-03-14 20:30
WuXi Biologics Wins CMO Leadership Awards in All Six Core Categories for Fifth Consecutive Year
2022-03-02 10:07
WuXi Biologics Statement
2022-02-08 11:08
WuXi Biologics Completes GMP Inspection by South Korea's Ministry of Food and Drug Safety for Drug Substance Facility
2022-01-18 10:50
WuXi Biologics Launches a New GMP Commercial Drug Product Facility
2021-11-01 10:19
WuXi Biologics Completes GMP Inspection by Health Canada for Drug Substance Facility
2021-10-28 08:30
WuXi Biologics Received First Manufacturing License from Japan and Completed 12 Global Regulatory Inspections in 2021 Year to Date
2021-09-01 14:12
WuXi Biologics Reports Strong 2021 Interim Results
2021-08-23 20:59
WuXi Biologics Biosafety Testing Facility Received Second EMA GMP Certificate
2021-08-02 20:13
WuXi Biologics Received Commercial Manufacturing License from German Health Authorities for its German Drug Product Facility
2021-07-26 18:00
WuXi XDC and LegoChem Biosciences Signed Memorandum of Understanding for the Development and Manufacturing of Antibody-drug Conjugates
2021-06-10 08:30
WuXi Biologics and OncoC4 Establish Exclusive CDMO Partnership
2021-05-27 08:30
WuXi Biologics and WuXi STA Jointly Established WuXi XDC to Provide Fully Integrated Bioconjugate CDMO Services
2021-05-14 08:30
WuXi Biologics Completed Three Acquisitions to Enhance its Global Network
2021-05-07 08:30
WuXi Biologics Receives 2021 Asia-Pacific Bioprocessing Excellence Award from IMAPAC
2021-04-13 17:00
WuXi Biologics Successfully Completed Pre-License Inspection and Routine GMP Inspection by U.S. FDA
2021-04-07 08:22
2020 Results Record High Despite a Challenging Year
2021-03-23 20:59
WuXi Biologics to Acquire CMAB and Form Strategic Partnership with CBC Group
2021-03-18 08:59
1
2
3
4
5
8